H pylori eradication: A randomized prospective study of triple therapy with or without ecabet sodium

Table 1 Demographic data and endoscopic findings of 257 patients with H pylori infection who were randomly assigned to standard triple therapy (group A) or triple therapy plus ecabet sodium (group B)

	Group A	Group B	P value
Patients	129	128
Age (yr) (mean ± SD)	54.3 ± 13.2	53.4 ± 12.4	0.562
Gender (male/female)	68/61	80/48	0.112
BMI (kg/m2) (mean ± SD)	23.3 ± 2.9	23.2 ± 3.0	0.768
Smoking	32 (24.8%)	32 (25.0%)	0.971
Alcohol consumption	40 (31.0%)	56 (43.8%)	0.035
Endoscopic findings			0.333
Gastric ulcer	62	66
Duodenal ulcer	37	26
Gastroduodenal ulcer	8	6
Gastric cancer1	7	5
Gastric MALT lymphoma	0	1
Gastritis	15	24

¹Patients who had received endoscopic treatment for early gastric cancer or adenoma.